<DOC>
	<DOCNO>NCT01032187</DOCNO>
	<brief_summary>The purpose study determine amphotericin B effective visceral leishmaniasis Brazilian child . Amphotericin B compare meglumine antimoniate current approve drug use disease Brazil .</brief_summary>
	<brief_title>Amphotericin B Treat Visceral Leishmaniasis Brazilian Children</brief_title>
	<detailed_description />
	<mesh_term>Leishmaniasis</mesh_term>
	<mesh_term>Leishmaniasis , Visceral</mesh_term>
	<mesh_term>Amphotericin B</mesh_term>
	<mesh_term>Liposomal amphotericin B</mesh_term>
	<mesh_term>Amphotericin B , deoxycholate drug combination</mesh_term>
	<mesh_term>Meglumine antimoniate</mesh_term>
	<mesh_term>Deoxycholic Acid</mesh_term>
	<criteria>Clinical symptom visceral leishmaniasis : fever plus hepatomegaly splenomegaly Diagnosis visceral leishmaniasis confirm parasite visualization bone marrow smear positive serology ( indirect immunofluorescent antibody test rK39 rapid test ) positive kDNA PCR test Any follow laboratory finding Total serum bilirubin high 2,5 mg/dL Serum SGOT high 5 time upper normal level Serum SGPT high 5 time upper normal level Prothrombin time concentration lower 70 % Abnormal serum creatinine Any follow sign symptom Generalized edema Severe malnutrition Systemic inflammatory response syndrome Any follow condition HIV infection/disease Diabetes Corticoid immunosuppressive drug use Symptomatic heart diseases Chronic hepatic renal disease Lupus erythematosus</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>12 Years</maximum_age>
	<verification_date>March 2011</verification_date>
	<keyword>Visceral leishmaniasis</keyword>
	<keyword>Amphotericin B deoxycholate</keyword>
	<keyword>Meglumine antimoniate</keyword>
	<keyword>Children</keyword>
	<keyword>Brazil</keyword>
</DOC>